$HOOD

Morgan Stanley Just Upgraded Robinhood Markets Inc. (HOOD). Here’s Why

Morgan Stanley upgraded Robinhood (HOOD) to Overweight, raising its price target to $150. The firm cites Robinhood's expanding product ecosystem, including prediction markets, as drivers for increased customer revenue. Robinhood's Q2 event-contract volume surged to 13.6 billion, with revenue from these contracts reaching $156 million. However, trading activity remains a key risk due to its significant contribution to revenue.

Original reporting
Published Sep 2, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley Just Upgraded Robinhood Markets Inc. (HOOD). Here’s Why — source image
Decision brief

The 30-second read

$HOODBullishMed
01

Why it matters

The upgrade reflects confidence in these new revenue streams, but highlights ongoing reliance on trading activity.

02

Market read

Analyst upgrade could drive short-term buying in HOOD and influence sentiment toward retail brokerages.

03

What to watch

Exposure to crypto volatility and reliance on market activity remain risks.

Relevance 7/10Novelty 8/10Timing: post-upgrade today

Background

Robinhood is expanding into subscriptions, banking, credit, and prediction markets to diversify revenue.

Company-level read

Ticker impact

$HOODBullishHigh confidence
Context

Morgan Stanley upgraded Robinhood to Overweight and raised the price target to $150, indicating fresh bullish sentiment.

Expected impact

Potential short-term upside as investors adjust positions.

Evidence & confidence

Upgrade and higher target provide a clear actionable catalyst.

Market effects

Positive outlook may lift other retail brokerage stocks.

U.S. retail trading sector could see modest gains.

Limited to U.S. markets; no direct global effect.

Counterpoint

Upgrade may be premature if trading volumes decline or interest rates fall.

Key entities

  • Morgan Stanley

    Provided the Overweight upgrade and new price target.

  • Robinhood Markets Inc.

    Subject of the upgrade and revenue diversification efforts.

Related articles

$HOODMed

Robinhood gets second bullish Wall Street call in two days

Morgan Stanley upgraded Robinhood (HOOD) to Overweight, setting a $150 price target, citing improved revenue per user. Bernstein also reiterated its Outperform rating with a $160 target. Robinhood's Q2 2026 revenue rose 32% YoY to $1.31B, with net income up 48% to $573M. Event contracts and prediction markets revenue surged, while crypto trading revenue fell 38% to $100M, according to the company.

$HOODHigh

Morgan Stanley Upgrades HOOD, Cites Prediction Market Boom for $150 Target

Morgan Stanley upgraded Robinhood (HOOD) to Overweight, raising its price target to $150 from $124. Analyst Michael Cyprys cited growth in prediction markets, which generated $156M in Q2 revenue. Robinhood's prediction market revenue surpassed stock and crypto trading. Morgan Stanley increased its earnings estimates for 2026-2028 by 12%-15% and expects revenue to grow 23% annually to $8B by 2028.

$HOODHigh

Morgan Stanley upgrades Robinhood stock, raises target to $150

Morgan Stanley upgraded Robinhood (HOOD) to overweight, raising its target to $150 from $124, citing undervalued revenue potential from existing customers. Analyst Michael Cyprys highlighted increased assets, activity, and monetization per customer, along with the company's derivatives exchange, Rothera. The upgrade comes amid falling crypto volumes, with 22 of 28 analysts rating HOOD a buy or strong buy.

$HOODMed

Stocks making the biggest moves premarket: Nvidia, Robinhood, Novartis & more

Premarket movers: Chipmakers fell as Treasury yields rose, with Nvidia, AMD, and Micron down over 1%. Energy stocks climbed over 1% alongside oil prices. Robinhood gained 2% after a Morgan Stanley upgrade. Novartis rose 4% on positive MS drug trial data. Duolingo advanced 6% following an Evercore ISI upgrade. Medtronic gained 5% after raising its fiscal 2027 EPS outlook.

Morgan Stanley Just Upgraded Robinhood Markets Inc. (HOOD). Here’s Why — alphai